Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Platelet Rich Plasma for Erectile Dysfunction
NCT04357353Phase 3Terminated
- Sponsor
- University of Nebraska
- Start
- Apr 2021
- Primary completion
- Nov 2022
- Modality
- Adoptive Cell Transfer
- Countries
- 1
01
Overview
A Phase 3 trial of autologous platelet-rich plasma in erectile dysfunction (ED), sponsored by University of Nebraska. Started Apr 2021; status: terminated.
02
Drugs
autologous platelet-rich plasma
03
Conditions
erectile dysfunction (ED)
Beyond the preview
Go deeper on NCT04357353.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04357353.